Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy.

Diagnostics (Basel) · 2025 · PMC11764177 · PMID 39857069

Europe PMC DOI

hedged sentence

0.1230

closest p · 2.5× alpha

0.1230

boldest claim

The sentences

did not reach statistical significancep = 0.123not close (p > 0.1)

Although the 5-year OS was lower in the mEASIX high IPS-3 high group than in the mEASIX high IPS-3 low group, this difference did not reach statistical significance (72.3% vs. 93.4%, p = 0.123). 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.